Alan So

Title: Innovations by Alan So in Drug Delivery Technologies

Introduction

Alan So is an accomplished inventor based in Vancouver, Canada, known for his contributions to the fields of drug delivery and biomedical research. With a total of four patents to his name, he has focused on developing innovative solutions that enhance the effectiveness of medications, particularly in treating cancer.

Latest Patents

Alan's latest patent, titled "Derivatized Hyperbranched Polyglycerols," presents a groundbreaking formulation for drug delivery. This invention features derivatized hyperbranched polyglycerols (dHPGs) that consist of a core made from hyperbranched polyglycerol, which is modified with CCalkyl chains. The dHPG also includes a shell of hydrophilic substituents bound to the hydroxyl groups of the core. This novel formulation is designed to deliver drugs or biologically active moieties to various bodily systems, including the urinary tract, digestive tract, airways, vaginal cavity, cervix, and peritoneal cavity. The potential applications include treatments for cancer, wherein these compounds can improve drug uptake within tissues, significantly enhancing therapeutic efficacy. Moreover, the patent outlines methods for synthesizing these dHPGs.

Career Highlights

Alan So's professional journey includes notable positions at esteemed institutions such as the University of British Columbia and the Centre for Drug Research and Development. His work has paved the way for advancements in pharmaceutical research and has had a lasting impact on the methodologies employed for drug delivery.

Collaborations

Throughout his career, Alan has collaborated with distinguished colleagues such as Helen M. Burt and Donald Elliott Brooks. These partnerships have greatly influenced his research and contributed to the development of innovative medicinal formulations.

Conclusion

Alan So exemplifies the spirit of innovation in drug delivery technologies through his extensive research and patent contributions. His inventions, particularly the derivatized hyperbranched polyglycerols, hold promise for improving the treatment of various medical conditions, especially cancer. As research institutions and pharmaceutical companies continue to explore his work, Alan's contributions will undoubtedly play a significant role in advancing the field of drug delivery.